title: [Myasthenia in elderly patients: a series of 23 cases].
abstract: OBJECTIVE
  There is evidence that myasthenia gravis is substantially underdiagnosed in older people, for which diagnosis and treatment may be difficult.
  
  
  METHODS
  We report on a series of 23 cases of myasthenia gravis diagnosed after the age of 65. Diagnosis was ascertained by compatible symptoms, associated with electrophysiological evidence and/or presence of antibodies to the acetylcholine receptor (AchRAb) and/or positive prostigmine test.
  
  
  RESULTS
  Twelve female and 11 male patients were identified, with a mean age of 77 (range: 66-89). Initial symptoms were ocular in 8 cases (35%), bulbar and ocular in 9 cases (39%), generalized in 6 cases (26%). Diagnosis was delayed in many patients (mean delay 31+/-47 months). Prostigmine test was positive in 16 cases (100%), AchRAb were positive in 19/23 cases (83%). Only one thymoma was found. Other diagnoses than myasthenia gravis, mainly stroke, were often considered. Treatment with anticholinesterase drugs, prescribed in all cases, has been able to control symptoms in only 3 cases. Corticosteroids were used in 10 cases, azathioprine or mycophenolate mofetil in 14 cases, intravenous immunoglobulins in 8 cases, and plasma exchanges in 2 cases. Thymectomy was performed on one patient with thymoma. Three patients were hospitalized in intensive care units for several weeks, and 3 patients died from their myasthenia.
  
  
  CONCLUSIONS
  Diagnosis of myasthenia gravis is often missed or delayed in the elderly, because of a broad differential diagnosis in older people, and because the high incidence of the disease in middle and old age is often overlooked. The outcome of myasthenia gravis in older people is far from simple, and immunomodulation proves to be necessary in most cases. However, quality of life of surviving patients appears good.
authors.affiliation: Service de médecine interne, hôpital Nord, CHU de Saint-Etienne, 42055 Saint-Etienne cedex 02, France.
authors.forename: F
authors.initials: F
authors.lastname: Durand
authors.forename: J-P
authors.initials: JP
authors.lastname: Camdessanché
authors.forename: L
authors.initials: L
authors.lastname: Jomir
authors.forename: J-C
authors.initials: JC
authors.lastname: Antoine
authors.forename: P
authors.initials: P
authors.lastname: Cathébras
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000368:Aged; D000369:Aged, 80 and over; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D003937:Diagnosis, Differential; D003951:Diagnostic Errors; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D015994:Incidence; D008297:Male; D009157:Myasthenia Gravis / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology / Q000601:surgery; D013934:Thymectomy
chemical_list: D000305:Adrenal Cortex Hormones; D002800:Cholinesterase Inhibitors; D016756:Immunoglobulins, Intravenous